Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031 - 广州辰宇信息咨询有限公司WIN MarketResearch Co.,Ltd

Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Published Date: 2025-03-31 | Pages: 71 | Tables: 67 | Medical Care

USD 4250.00 (Single License) USD 6000.00 (Multi License) USD 8000.00 (Enterprise License)

Description
Table of Contents
Tables and Figures
Research

The global ICAD (Intracranial Atherosclerotic Disease) Pathology market size was US$ 206 million in 2024 and is forecast to a readjusted size of US$ 368 million by 2031 with a CAGR of 8.8% during the forecast period 2025-2031.
Intracranial atherosclerotic disease is the progressive narrowing of the cerebral arteries within the skull (intracranial). The arteries that supply oxygen-enriched blood to the brain are the carotid arteries and the vertebral arteries. The circle of Willis is the area at the base of the brain that joins these arteries. Stenosis (narrowing) of the artery walls in intracranial atherosclerotic disease (ICAD) develops similarly to atherosclerosis of the heart: from the buildup of plaque, also known as an atherosclerotic lesion. The product in this report is Stent and PTA balloon for Treatment of ICAD.
Global ICAD (Intracranial Atherosclerotic Disease) Pathology key players include Stryker, Balt, TERUMO, MicroPort, Acandis, etc. Global top five manufacturers hold a share about 90%. Asia-Pacific is the largest market, with a share about 45%, followed by North America, with a share about 25 percent. In terms of product, Stent is the largest segment, with a share about 80%. And in terms of application, the largest application is Hospital, followed by Clinic, etc.
The global ICAD (Intracranial Atherosclerotic Disease) Pathology market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Stryker
Balt
TERUMO
MicroPort
Acandis
By Type: (Dominant Segment vs High-Margin Innovation)
Stent
PTA Balloon
By Application: (Core Demand Driver vs Emerging Opportunity)
Hospital
Clinic
Other
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Stryker in Europe)
- Emerging Product Trends: Stent adoption vs. PTA Balloon premiumization
- Demand-Side Dynamics: Hospital growth in China vs. Clinic potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of ICAD (Intracranial Atherosclerotic Disease) Pathology market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., PTA Balloon in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Clinic in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the ICAD (Intracranial Atherosclerotic Disease) Pathology value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets

Research Methodology

The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:

★Stage 1 SECONDARY RESEARCH

The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.

★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES

After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.

★Stage 3 ANALYSIS OF THE GATHERED DATA

The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.

★Stage 4 QUANTITATIVE DATA

The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.

★Stage 5 QUALITY CONTROL

Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.

1 Market Overview
1.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Product Scope
1.2 ICAD (Intracranial Atherosclerotic Disease) Pathology by Type
1.2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2020 & 2024 & 2031)
1.2.2 Stent
1.2.3 PTA Balloon
1.3 ICAD (Intracranial Atherosclerotic Disease) Pathology by Application
1.3.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Estimates and Forecasts (2020-2031)
1.4.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size in Value Growth Rate (2020-2031)
1.4.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Region (2020-2025)
2.2.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Region (2020-2025)
2.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size and Prospective (2020-2031)
2.4.2 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size and Prospective (2020-2031)
2.4.3 China ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size and Prospective (2020-2031)
2.4.4 Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Historic Market Review by Type (2020-2025)
3.1.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2020-2025)
3.1.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Type (2020-2025)
3.1.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Type (2020-2025)
3.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Forecast by Type (2026-2031)
3.2.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Forecast by Type (2026-2031)
3.2.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Price Forecast by Type (2026-2031)
3.3 Different Types ICAD (Intracranial Atherosclerotic Disease) Pathology Representative Players
4 Global Market Size by Application
4.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Historic Market Review by Application (2020-2025)
4.1.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2020-2025)
4.1.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Application (2020-2025)
4.1.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Application (2020-2025)
4.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Forecast by Application (2026-2031)
4.2.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Forecast by Application (2026-2031)
4.2.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in ICAD (Intracranial Atherosclerotic Disease) Pathology Application
5 Competition Landscape by Players
5.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Players (2020-2025)
5.2 Global Top ICAD (Intracranial Atherosclerotic Disease) Pathology Players by Revenue (2020-2025)
5.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ICAD (Intracranial Atherosclerotic Disease) Pathology as of 2024)
5.4 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of ICAD (Intracranial Atherosclerotic Disease) Pathology, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of ICAD (Intracranial Atherosclerotic Disease) Pathology, Product Type & Application
5.7 Global Key Manufacturers of ICAD (Intracranial Atherosclerotic Disease) Pathology, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Company
6.1.1.1 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Company (2020-2025)
6.1.1.2 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Company (2020-2025)
6.1.2 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Breakdown by Type (2020-2025)
6.1.3 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Breakdown by Application (2020-2025)
6.1.4 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Company
6.2.1.1 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Company (2020-2025)
6.2.1.2 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Company (2020-2025)
6.2.2 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Breakdown by Type (2020-2025)
6.2.3 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Breakdown by Application (2020-2025)
6.2.4 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Company
6.3.1.1 China ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Company (2020-2025)
6.3.1.2 China ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Company (2020-2025)
6.3.2 China ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Breakdown by Type (2020-2025)
6.3.3 China ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Breakdown by Application (2020-2025)
6.3.4 China ICAD (Intracranial Atherosclerotic Disease) Pathology Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Company
6.4.1.1 Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Company (2020-2025)
6.4.1.2 Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Company (2020-2025)
6.4.2 Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Breakdown by Type (2020-2025)
6.4.3 Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Breakdown by Application (2020-2025)
6.4.4 Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Major Customer
6.4.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Stryker
7.1.1 Stryker Company Information
7.1.2 Stryker Business Overview
7.1.3 Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Products Offered
7.1.5 Stryker Recent Development
7.2 Balt
7.2.1 Balt Company Information
7.2.2 Balt Business Overview
7.2.3 Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Products Offered
7.2.5 Balt Recent Development
7.3 TERUMO
7.3.1 TERUMO Company Information
7.3.2 TERUMO Business Overview
7.3.3 TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Gross Margin (2020-2025)
7.3.4 TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Products Offered
7.3.5 TERUMO Recent Development
7.4 MicroPort
7.4.1 MicroPort Company Information
7.4.2 MicroPort Business Overview
7.4.3 MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Gross Margin (2020-2025)
7.4.4 MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Products Offered
7.4.5 MicroPort Recent Development
7.5 Acandis
7.5.1 Acandis Company Information
7.5.2 Acandis Business Overview
7.5.3 Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Products Offered
7.5.5 Acandis Recent Development
8 ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturing Cost Analysis
8.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of ICAD (Intracranial Atherosclerotic Disease) Pathology
8.4 ICAD (Intracranial Atherosclerotic Disease) Pathology Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Distributors List
9.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Customers
10 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Dynamics
10.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Trends
10.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Drivers
10.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Challenges
10.4 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer

List of Tables
Table 1. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units) by Region (2020-2025)
Table 5. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Region (2020-2025)
Table 6. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share by Region (2020-2025)
Table 8. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units) Forecast by Region (2026-2031)
Table 9. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share Forecast by Region (2026-2031)
Table 10. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share Forecast by Region (2026-2031)
Table 12. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (Units) & (2020-2025)
Table 13. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Share by Type (2020-2025)
Table 14. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Type (USD/Unit) & (2020-2025)
Table 16. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (Units) & (2026-2031)
Table 17. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Type (USD/Unit) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (Units) & (2020-2025)
Table 21. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Share by Application (2020-2025)
Table 22. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Application (USD/Unit) & (2020-2025)
Table 24. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (Units) & (2026-2031)
Table 25. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Application (USD/Unit) & (2026-2031)
Table 27. New Sources of Growth in ICAD (Intracranial Atherosclerotic Disease) Pathology Application
Table 28. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Company (Units) & (2020-2025)
Table 29. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Share by Company (2020-2025)
Table 30. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share by Company (2020-2025)
Table 32. Global ICAD (Intracranial Atherosclerotic Disease) Pathology by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ICAD (Intracranial Atherosclerotic Disease) Pathology as of 2024)
Table 33. Global Market ICAD (Intracranial Atherosclerotic Disease) Pathology Average Price by Company (USD/Unit) & (2020-2025)
Table 34. Global Key Manufacturers of ICAD (Intracranial Atherosclerotic Disease) Pathology, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of ICAD (Intracranial Atherosclerotic Disease) Pathology, Product Type & Application
Table 36. Global Key Manufacturers of ICAD (Intracranial Atherosclerotic Disease) Pathology, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Company (2020-2025) & (Units)
Table 39. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Company (2020-2025)
Table 40. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Company (2020-2025)
Table 42. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2020-2025) & (Units)
Table 43. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Type (2020-2025)
Table 44. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2020-2025) & (Units)
Table 45. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Application (2020-2025)
Table 46. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Company (2020-2025) & (Units)
Table 47. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Company (2020-2025)
Table 48. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Company (2020-2025)
Table 50. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2020-2025) & (Units)
Table 51. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Type (2020-2025)
Table 52. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2020-2025) & (Units)
Table 53. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Application (2020-2025)
Table 54. China ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Company (2020-2025) & (Units)
Table 55. China ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Company (2020-2025)
Table 56. China ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Company (2020-2025) & (US$ Million)
Table 57. China ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Company (2020-2025)
Table 58. China ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2020-2025) & (Units)
Table 59. China ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Type (2020-2025)
Table 60. China ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2020-2025) & (Units)
Table 61. China ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Application (2020-2025)
Table 62. Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Company (2020-2025) & (Units)
Table 63. Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Company (2020-2025)
Table 64. Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Company (2020-2025) & (US$ Million)
Table 65. Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Company (2020-2025)
Table 66. Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2020-2025) & (Units)
Table 67. Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Type (2020-2025)
Table 68. Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2020-2025) & (Units)
Table 69. Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Application (2020-2025)
Table 70. Stryker Company Information
Table 71. Stryker Description and Business Overview
Table 72. Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Product
Table 74. Stryker Recent Development
Table 75. Balt Company Information
Table 76. Balt Description and Business Overview
Table 77. Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Product
Table 79. Balt Recent Development
Table 80. TERUMO Company Information
Table 81. TERUMO Description and Business Overview
Table 82. TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Product
Table 84. TERUMO Recent Development
Table 85. MicroPort Company Information
Table 86. MicroPort Description and Business Overview
Table 87. MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Product
Table 89. MicroPort Recent Development
Table 90. Acandis Company Information
Table 91. Acandis Description and Business Overview
Table 92. Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Product
Table 94. Acandis Recent Development
Table 95. Production Base and Market Concentration Rate of Raw Material
Table 96. Key Suppliers of Raw Materials
Table 97. ICAD (Intracranial Atherosclerotic Disease) Pathology Distributors List
Table 98. ICAD (Intracranial Atherosclerotic Disease) Pathology Customers List
Table 99. ICAD (Intracranial Atherosclerotic Disease) Pathology Market Trends
Table 100. ICAD (Intracranial Atherosclerotic Disease) Pathology Market Drivers
Table 101. ICAD (Intracranial Atherosclerotic Disease) Pathology Market Challenges
Table 102. ICAD (Intracranial Atherosclerotic Disease) Pathology Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources

List of Figures
Figure 1. ICAD (Intracranial Atherosclerotic Disease) Pathology Product Picture
Figure 2. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Type in 2024 & 2031
Figure 4. Stent Product Picture
Figure 5. PTA Balloon Product Picture
Figure 6. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 7. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Application in 2024 & 2031
Figure 8. Hospital Examples
Figure 9. Clinic Examples
Figure 10. Other Examples
Figure 11. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate (2020-2031) & (US$ Million)
Figure 13. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units) Growth Rate (2020-2031)
Figure 14. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Price Trends Growth Rate (2020-2031) & (USD/Unit)
Figure 15. ICAD (Intracranial Atherosclerotic Disease) Pathology Report Years Considered
Figure 16. Global Market ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 17. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Region: 2020 VS 2024
Figure 18. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units) Growth Rate (2020-2031)
Figure 20. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (US$ Million) Growth Rate (2020-2031)
Figure 21. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units) Growth Rate (2020-2031)
Figure 22. China ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (US$ Million) Growth Rate (2020-2031)
Figure 23. China ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units) Growth Rate (2020-2031)
Figure 24. Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (US$ Million) Growth Rate (2020-2031)
Figure 25. Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units) Growth Rate (2020-2031)
Figure 26. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share by Type (2020-2025)
Figure 27. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Share by Type (2026-2031)
Figure 28. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share by Type (2026-2031)
Figure 29. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share by Application (2020-2025)
Figure 30. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Growth Rate by Application in 2020 & 2024
Figure 31. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Share by Application (2026-2031)
Figure 32. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share by Application (2026-2031)
Figure 33. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Share by Company (2024)
Figure 34. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share by Company (2024)
Figure 35. Global 5 Largest ICAD (Intracranial Atherosclerotic Disease) Pathology Players Market Share by Revenue in ICAD (Intracranial Atherosclerotic Disease) Pathology: 2020 & 2024
Figure 36. ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 37. Manufacturing Cost Structure of ICAD (Intracranial Atherosclerotic Disease) Pathology
Figure 38. Manufacturing Process Analysis of ICAD (Intracranial Atherosclerotic Disease) Pathology
Figure 39. ICAD (Intracranial Atherosclerotic Disease) Pathology Industrial Chain
Figure 40. Channels of Distribution (Direct Vs Distribution)
Figure 41. Distributors Profiles
Figure 42. Bottom-up and Top-down Approaches for This Report
Figure 43. Data Triangulation
Figure 44. Key Executives Interviewed

Our Clients